Breadcrumb

  1. Insights

All Perspectives

10014 total results. Page 159 of 401.

On Friday, November 5, 2021, the Centers for Medicare and Medicaid Services (CMS) issued a comprehensive interim final rule, the Omnibus COVID-19 Health Care Staff Vaccination rule.

Trade associations and other cooperatives should heed the warning implied by the US Department of Justice’s aggressive stance in a recent court filing

Deputy Attorney General Lisa O. Monaco’s Keynote Address  at ABA’s National Institute on White Collar Crime

November 17, 2021

Stephanie Trunk will participate in the American Conference Institute’s Passport to Proficiency on Rx Drug Pricing and Rebate Fundamentals, an intensive virtual training series focusing on essential pricing and rebate concepts under Medicaid, Medicare, and other related government payor programs.

Schiff Hardin LLP is pleased to announce that Partner Mir Ali has been recognized among Crain’s Chicago Business’ Notable Military Veteran Executives in 2021.

On October 29, 2021, the FDA issued two Guidances that implement a new requirement of the federal Food, Drug, and Cosmetic Act (FDCA) that all registrants of drug establishments – both domestic and foreign – must file a report on the amount of each listed drug produced over the preceding year.

Headlines that Matter for Companies and Executives in Regulated Industries.

On November 4, 2021, CMS issued its Omnibus Staff Vaccination Rule, mandating that all Medicare and Medicaid-certified facilities regulated under Medicare health and safety standards require that their employees be fully vaccinated against COVID-19 by January 4, 2022.

On Thursday, November 4, the Occupational Safety and Health Administration (OSHA) published an emergency temporary standard (ETS) making good on President Biden’s pledge to require private employers with 100 or more employees to implement vaccination-or-testing mandates for their employees.

Michigan Governor Gretchen Whitmer today signed into law a bill that eliminates the state’s six percent sales tax on menstrual products, ending a multi-year legislative effort and a class action lawsuit that challenged the legality of the sales and use tax.

Schiff Hardin LLP has received 39 top-tier rankings in the 2022 edition of U.S. News – Best Lawyers® “Best Law Firms,” nationally recognizing the firm’s premier practices.

November 4, 2021

American Bankers Association 2021 Wealth Management and Trust Webinar Series Suite

On November 4, 2021, the Occupational Safety and Health Administration (OSHA) issued its long-awaited emergency temporary standard (ETS) mandating that large employers require employees to be fully vaccinated against COVID-19 or obtain weekly tests and wear face coverings in the workplace.  

Brands Must Ensure Forced Labor is Not Used and Environmental Claims are Accurate

On November 2, 2021, CMS published the 2022 Hospital Outpatient Prospective Payment System Final Rule that addressed its previously-proposed penalties for hospital non-compliance with price reporting requirements.

November 3, 2021

Family Wealth Alliance 2021 Fall Forum

CMS published the 2022 Physician Fee Schedule Final Rule on November 2, 2021. The Rule keeps intact CMS’s temporary physician supervision requirements related to the provision of telehealth services.

On October 31, 2021, the Department of Commerce and the Office of the US Trade Representative announced an agreement with the European Union (EU) to remove the 25% additional tariffs on steel and 10% additional tariffs on aluminum pursuant to Section 232 of the Trade Expansion Act of 1962.

Snidely Whiplash kidnaps Nell and, in the show’s opening, ties her to the railroad tracks to get even with his nemesis, Dudley Do-Right, of the famed Royal Canadian Mounted Police. Menacing music plays. 

Regulatory Guidance Aims to Apply Banking Regulations to Stablecoin Issuers

A recent announcement by the US Environmental Protection Agency (EPA) got the immediate attention of companies that manufacture, process, or import finished products for sale and use by consumer, commercial, and industrial customers. 

Schiff Hardin LLP represented the underwriters in Biofrontera Inc.’s $18 million initial public offering of 3,600,000 units.

Schiff Hardin LLP served as underwriter’s counsel for Deep Medicine Acquisition Corp.’s upsized initial public offering raising gross proceeds of $126.5 million.